Utilizing Finnish nationwide RWD to create an external control arm to a clinical trial
24 Nov 2022, 16:00 CET
Webinar

The high quality Real-World-Data available in Finland provides a valuable opportunity for pharmaceutical companies to develop external controls arms.

In this webinar the speaker will provide a high-level overview of the specifics of how to develop an external control arm, including an introduction to the available data-sources.

Speaker: Jussi Leinonen

Jussi graduated in 2009 from University of Tampere with a MD degree. He continued his education in Hebrew University of Jerusalem (PhD) and recently in Quantic School of Business and Technology (eMBA).

He has worked at Bayer for five years after many years of work as a clinical practitioner under several therapeutic areas combined with research experience in basic and preclinical regenerative medicine. In his current position as strategic project lead at Bayer's global R&D, he is responsible in managing and leading portfolio of data insights projects and initiatives in clinical research.

He constantly explore various disciplines to broaden his skills and understanding in the pharmaceutical and healthcare sector. His current areas of interest are data science, clinical research, precision medicine, regenerative biology, corporate strategy, leadership and organizational culture.